The honest answer is that a screening colonoscopy is supposed to cost you nothing, and that a large number of people get a bill anyway. Both of those things are true at the same time, and the gap between them is almost entirely about billing codes rather than medicine.

Two rule changes in the last few years closed the biggest loopholes. Knowing what they cover, and the handful of charges they still do not, is the difference between a $0 statement and a four-figure surprise.

The short answer

With in-network private insurance, a screening colonoscopy in the recommended age range should carry no deductible, copay, or coinsurance. A colonoscopy following a positive stool test is also required to be covered without cost sharing. On Medicare, a screening colonoscopy is free unless a polyp is removed, in which case a 15% coinsurance applies through 2026.

Without insurance, the range commonly quoted runs from roughly $1,200 to $4,800, driven mostly by whether it is done at a surgery center or a hospital.

Why a screening colonoscopy should cost you nothing

The Affordable Care Act requires most private plans to cover preventive services that carry an A or B rating from the U.S. Preventive Services Task Force, with no cost sharing when delivered in network.

Colorectal cancer screening qualifies. The current USPSTF recommendation is a grade B for adults aged 45 to 49 and a grade A for adults aged 50 to 75, with selective screening from 76 to 85 based on individual health. The accepted screening options and intervals include:

  • Colonoscopy every 10 years
  • FIT (fecal immunochemical test) every year
  • Stool DNA-FIT every 1 to 3 years
  • CT colonography every 5 years
  • Flexible sigmoidoscopy every 5 years, or every 10 years with annual FIT

Two limits are worth naming. The protection applies to in-network care, and grandfathered plans and short-term limited-duration plans are not bound by it. If you are on a plan bought outside the marketplace, confirm before assuming.

What turns a free screening into a bill

Six things account for nearly all unexpected colonoscopy charges:

  1. Reclassification after a polyp is found. Historically the single biggest cause. The procedure starts as screening and, once a polyp is removed, gets coded as therapeutic. Modifiers exist specifically to preserve the preventive designation, but they have to be applied.
  2. A symptom in the chart. If you mentioned rectal bleeding, abdominal pain, or a change in bowel habits, the procedure may be coded diagnostic from the outset, which is a different benefit entirely. This is not fraud, it is coding rules, and it is worth understanding before your intake appointment.
  3. Out-of-network clinicians at an in-network facility. Anesthesiology and pathology are the usual offenders. Federal surprise-billing protections cover much of this now, but confirming network status in advance is still faster than appealing afterward.
  4. Facility fees. Hospital outpatient departments bill a facility charge that ambulatory surgery centers generally do not.
  5. Bowel prep. The prep is usually a separate pharmacy claim with its own coverage rules. Newer low-volume preps are frequently the ones not covered.
  6. Surveillance rather than screening. If you have had polyps before, your next colonoscopy may be classified as surveillance, which some plans treat differently from a first screening.

What changed for colonoscopy after a positive stool test

This used to be the cruelest bill in preventive medicine. A patient chose a free at-home stool test, got a positive result, and then received a large bill for the colonoscopy that the positive result made necessary. The colonoscopy was treated as diagnostic because the stool test had already flagged something.

Federal guidance closed that gap. In FAQs About Affordable Care Act Implementation Part 51, released January 10, 2022, the Departments of Labor, Health and Human Services, and the Treasury stated that plans and issuers must cover, without cost sharing, a colonoscopy conducted after a positive non-invasive stool-based screening test. That applies to plan or policy years beginning on or after May 31, 2022.

Medicare followed with a comparable policy effective January 1, 2023: a follow-up colonoscopy after a positive Medicare-covered stool-based test is treated as a screening colonoscopy rather than a diagnostic one.

The practical implication is that stool-based screening is now a genuinely lower-risk financial choice than it was before 2022. If you have been avoiding at-home screening options because you were worried about the follow-up bill, that specific concern has largely been addressed.

How does Medicare handle it in 2026?

Medicare Part B covers screening colonoscopy with no coinsurance and no deductible. Frequency depends on risk: generally every 10 years for average risk, and more often for people at increased risk.

The exception is polyp removal. When a screening colonoscopy converts to a diagnostic or therapeutic procedure, a reduced coinsurance applies, and it is on a legislated phase-out schedule:

  • 2023 to 2026: 15% coinsurance
  • 2027 to 2029: 10% coinsurance
  • 2030 onward: no coinsurance

The Part B deductible is waived in this scenario. So in 2026, a Medicare patient whose screening colonoscopy includes a polypectomy pays 15% of the Medicare-approved amount rather than nothing. That is a real charge, though far below the pre-2023 20%.

Medicare Advantage plans must cover the same preventive benefit, but their network rules and any supplemental cost sharing are plan-specific.

What do people actually end up paying?

A study in JAMA Network Open looked at exactly this question using claims from 80,951 patients who completed non-invasive stool-based screening between 2014 and 2019: 74,235 with commercial insurance and 6,716 with Medicare.

Among those who went on to a follow-up colonoscopy, out-of-pocket costs above $0 appeared in 48.2% of commercial claims and 77.9% of Medicare claims. Mean out-of-pocket costs ranged from $99 to $231 depending on which screening test came first. Of the patients who had the follow-up colonoscopy within six months, 57.8% had polyps removed, which was associated with higher cost sharing.

The important caveat is the date range. Those claims predate both the 2022 private-plan guidance and the 2023 Medicare change. The numbers describe the problem the rules were written to fix, not what should happen today. They are useful as a measure of how routinely this went wrong, and as a reason to check your explanation of benefits rather than assume.

What does it cost without insurance?

Consumer price estimates generally put the range at roughly $1,200 to $4,800, and the spread is not random. The largest driver is site of service. The same procedure by the same physician typically costs considerably less at an ambulatory surgery center than at a hospital outpatient department, because of the facility fee.

Three things reduce the cash price meaningfully:

  • Ask for the self-pay bundled rate. Many practices quote a single all-in price covering physician, facility, anesthesia, and pathology that is far below the sum of billed charges. It is rarely offered unprompted.
  • Choose an ambulatory surgery center. Ask explicitly where the procedure will be performed.
  • Check for free or reduced-cost screening programs. The CDC's Colorectal Cancer Control Program and many hospital charity care policies, health centers, and state programs cover screening for uninsured people in the eligible age range.

If cost is the barrier, a FIT test is a legitimate alternative to consider with your clinician. It costs a fraction of a colonoscopy, and annual FIT is an accepted USPSTF screening strategy, not a second-tier option.

How to avoid a surprise bill

Before scheduling, work through this list. It takes about twenty minutes and it is the highest-return twenty minutes in the whole process.

  • Call your insurer and ask specifically: "Is this covered as preventive screening with no cost sharing, and what happens to my cost sharing if a polyp is removed?" Get a reference number for the call.
  • Ask the ordering office what diagnosis code will be submitted. Screening and diagnostic codes produce very different bills.
  • Confirm the facility, the gastroenterologist, the anesthesia provider, and the pathology lab are all in network. Ask each separately.
  • Ask whether it will be done at a hospital or an ambulatory surgery center.
  • Ask which bowel prep will be prescribed and whether your plan covers it. If not, ask for a covered alternative. colonoscopy.md's prep guide covers the differences between the options.
  • If you have symptoms, ask directly how that affects coding, so you are not surprised later.

What if the bill already arrived?

Unexpected colonoscopy bills are frequently reversed, so do not pay one before checking it.

  1. Request an itemized bill and compare it against your explanation of benefits.
  2. Check the codes. If the procedure began as screening, ask the billing office whether the appropriate modifier was applied to preserve the preventive designation.
  3. If it followed a positive stool test, cite the January 2022 federal guidance directly. Billing departments frequently have not encountered it.
  4. File a formal appeal with your insurer. Internal appeals are free, and denials are overturned often enough to be worth the effort.
  5. Escalate to your state insurance department if the internal appeal fails.

One last point that gets lost in cost discussions: cost is a reason to plan the screening carefully, not to skip it. Colorectal cancer is one of the few cancers that screening can prevent outright, by removing precancerous polyps before they become cancer, and incidence in younger adults has been rising. The financial protections described above exist precisely so that the price is not the deciding factor.